Zdrowie i gospodarka · 09/05/2019

FDA Releases Draft Guidance on Using Real-World Data for Drug and Biologics Submissions

The FDA is announcing the availability of a draft guidance to encourage the use of real-world data in drug and biologics submissions, providing instructions on how to document the inclusion of real-world evidence.